Medical News

RSS

TUM researchers uncover signaling pathways that play vital role in self-renewal of blood stem cells

Stem cells have two important capabilities: they can develop into a wide range of cell types and simultaneously renew themselves, creating fresh stem cells. Using a model of the blood forming (hematopoietic) system, researchers at the Technical University of Munich have now been able to precisely determine, which signaling pathways play an essential role in the self-renewal of blood stem cells.

4 Nov 2015

Research shows link between absence of RB protein and long-term survival rates in lung cancer patients

November is Lung Cancer Awareness Month, highlighting the number one cause of cancer-related death in North America. While prognosis for the most common form, adenocarcinoma, has remained poor, new research has shown a link between the absence of a specific protein and improved patient outcomes.

4 Nov 2015

Psychoactive drugs can help sedentary people to exercise, suggests Kent endurance expert

Endurance expert suggests drugs could help 'lazy people' exercise In what has been described as 'doping for lazy people' a University of Kent endurance expert has advocated the use of psychoactive drugs to encourage sedentary people to exercise.

4 Nov 2015

Northeastern University researchers create 3-D printing technology to develop patient-specific products

A team of researchers at Northeastern University has developed an innovative 3-D printing technology that uses magnetic fields to shape composite materials--mixes of plastics and ceramics--into patient-specific products. The biomedical devices they are developing will be both stronger and lighter than current models and, with their customized design, ensure an appropriate fit.

4 Nov 2015

Samumed to present preclinical and clinical data on Wnt pathway for OA treatment at ACR 2015

Samumed, LLC, a leader in tissue regeneration, announced today that it will present preclinical and clinical data on a small molecule modulator of the Wnt pathway (SM04690, an investigational new drug) for potential disease modifying treatment of osteoarthritis (OA) of the knee at 2015 American College of Rheumatology Annual Meeting.

4 Nov 2015

New computational method helps predict adverse drug reaction better than traditional computing methods

A new integrated computational method helps predicting adverse drug reaction--which are often lethal--more reliably than with traditional computing methods. This improved ability to foresee the possible adverse effects of drugs may entail saving many lives in the future.

4 Nov 2015

‘Zero pressure’ mattress solutions to be showcased at MEDICA 2015

‘Stop the Pressure’ is the message from pressure ulcer specialist Rober, who is showcasing their wide range of innovative mattresses in support of Worldwide STOP Pressure Ulcer Day at MEDICA 2015, the world’s largest healthcare technology exhibition.

4 Nov 2015

Review of haemodynamics in stent development shows spiral flow may be key to improving peripheral arterial stent performance

Vascular Flow Technologies, the medical device company using proprietary Spiral Laminar Flow (SLF™) technology to replicate natural blood flow for enhanced patient outcomes, today announces that 'Haemodynamics and Flow Modification Stents for Peripheral Arterial Disease: A Review’, co-authored by VFT’s non-executive Medical Director Graeme Houston, has been published in the Annals of Biomedical Engineering. The paper reviews the importance of haemodynamics in stent development as a method of improving patency and longevity of the stent.

4 Nov 2015

Innovative immunotherapy clinical trial underway at The University of Kansas Cancer Center

A novel immunotherapy clinical trial underway now at The University of Kansas Cancer Center has enrolled the first patients in the world to receive what many doctors and researchers believe is the future of cancer treatment.

4 Nov 2015

Surgical startup seeks funding to build virtual reality training library

Medical Realities, a pioneering medical training startup, today announced that it is raising £400,000 in new investment to improve surgical education by creating a series of virtual and augmented reality training tutorials.

4 Nov 2015

INVO Bioscience obtains de novo clearance from FDA for INVOcell fertility treatment

INVO Bioscience, Inc., a medical device company focused on treatment option for patients diagnosed with infertility, today announced that the U.S. Food and Drug Administration has granted the Company's de novo request for the INVOcell.

4 Nov 2015

Medigus announces CMS’ publication of fee schedules for endoscopic fundoplication procedures under CPT code 43210 effective January 2016

Medigus Ltd., a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, today announced that following the American Medical Association’s (AMA) decision earlier this year to create a new Category I Current Procedural Terminology (CPT®) code for esophagogastric fundoplast...

3 Nov 2015

Ingenza and Imperial researchers work together to improve nasogastric feeding tube placement

Ingenza has teamed up with clinical scientists at Imperial College London to trial an improved diagnostic assay for confirming nasogastric (NG) tube placement. Professor George Hanna, Director of the National Institute for Health Research Diagnostic Evidence Co-operative London at Imperial College Healthcare NHS Trust, which specialises in In Vitro Diagnostics, explained: “Correct placement of NG tubes is vital, as accidental insertion of the tube into the lung instead of the gut can have serious consequences.

3 Nov 2015

Denator forms a new Scientific Advisory Board

Denator AB has announced that a new external expert advisory board has been formed. Karsten Fjärstedt, recently appointed as CEO comments, “It is a great honor for me to be entrusted to lead Denator forward in this new phase of development. With a pipeline of new exciting business opportunities and a strong Scientific Advisory Board (SAB) I am looking forward to realizing the full potential of the company technology”.

3 Nov 2015

Blood stem cell self-renewal dependent on surroundings

Stem cells have two important capabilities: they can develop into a wide range of cell types and simultaneously renew themselves, creating fresh stem cells. Using a model of the blood forming (hematopoietic) system, researchers at the Technical University of Munich (TUM) have now been able to precisely determine, which signaling pathways play an essential role in the self-renewal of blood stem cells. A particularly decisive role in this process is the interactive communication with surrounding tissue cells in the bone marrow.

3 Nov 2015

Approval to start trial of Videregen's replacement trachea technology

The INSPIRE consortium, led by Videregen Ltd, has received approval from the MHRA1 to start a UK clinical trial with its tissue engineered replacement trachea.

3 Nov 2015

Alnylam presents positive ongoing phase 2 open-label extension data for Patisiran and Revusiran

Alnylam Pharmaceuticals, Inc. has announced new results from its ongoing Phase 2 open-label extension (OLE) studies with patisiran and revusiran, investigational RNAi therapeutics targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR amyloidosis).

3 Nov 2015

Medical News

TUM researchers uncover signaling pathways that play vital role in self-renewal of blood stem cells

Research shows link between absence of RB protein and long-term survival rates in lung cancer patients

Psychoactive drugs can help sedentary people to exercise, suggests Kent endurance expert

Northeastern University researchers create 3-D printing technology to develop patient-specific products

Samumed to present preclinical and clinical data on Wnt pathway for OA treatment at ACR 2015

New computational method helps predict adverse drug reaction better than traditional computing methods

‘Zero pressure’ mattress solutions to be showcased at MEDICA 2015

Review of haemodynamics in stent development shows spiral flow may be key to improving peripheral arterial stent performance

Innovative immunotherapy clinical trial underway at The University of Kansas Cancer Center

Surgical startup seeks funding to build virtual reality training library

INVO Bioscience obtains de novo clearance from FDA for INVOcell fertility treatment

Medigus announces CMS’ publication of fee schedules for endoscopic fundoplication procedures under CPT code 43210 effective January 2016

Ingenza and Imperial researchers work together to improve nasogastric feeding tube placement

Denator forms a new Scientific Advisory Board

Blood stem cell self-renewal dependent on surroundings

Approval to start trial of Videregen's replacement trachea technology

Alnylam presents positive ongoing phase 2 open-label extension data for Patisiran and Revusiran

Misleading symptoms confuse management of older patients with post-HSE relapse

General psychiatric support warranted in MS patients

Standing one-quarter of the day linked to reduced likelihood of obesity

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News